Abstract
CoaBC, part of the vital coenzyme A biosynthetic pathway in bacteria, has recently been validated as a promising antimicrobial target. In this work, we employed native ion mobility-mass spectrometry to gain structural insights into the phosphopantothenoylcysteine synthetase domain of E. coli CoaBC. Moreover, native mass spectrometry was validated as a screening tool to identify novel inhibitors of this enzyme, highlighting the utility and versatility of this technique both for structural biology and for drug discovery.
© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Carboxy-Lyases / antagonists & inhibitors
-
Carboxy-Lyases / chemistry*
-
Carboxy-Lyases / metabolism
-
Dimerization
-
Drug Evaluation, Preclinical / methods*
-
Enzyme Inhibitors / chemistry
-
Escherichia coli / chemistry
-
Escherichia coli / drug effects
-
Escherichia coli / enzymology*
-
Escherichia coli / genetics
-
Escherichia coli Proteins / antagonists & inhibitors
-
Escherichia coli Proteins / chemistry*
-
Escherichia coli Proteins / metabolism
-
Kinetics
-
Mass Spectrometry / methods*
-
Multienzyme Complexes / antagonists & inhibitors
-
Multienzyme Complexes / chemistry*
-
Multienzyme Complexes / metabolism
-
Peptide Synthases / antagonists & inhibitors
-
Peptide Synthases / chemistry*
-
Peptide Synthases / metabolism
-
Protein Domains
Substances
-
Dfp protein, E coli
-
Enzyme Inhibitors
-
Escherichia coli Proteins
-
Multienzyme Complexes
-
Carboxy-Lyases
-
Peptide Synthases